No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr6:33943200-33944200 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
2 |
chr6:33943200-33944400 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
3 |
chr6:33943400-33944200 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
4 |
chr6:33943400-33944200 |
Bivalent Enhancer |
Fetal Brain Male |
brain
|
5 |
chr6:33943400-33944200 |
Bivalent/Poised TSS |
Fetal Brain Female |
brain
|
6 |
chr6:33943400-33944400 |
Bivalent Enhancer |
Fetal Thymus |
thymus
|
7 |
chr6:33943600-33944200 |
Bivalent/Poised TSS |
iPS-18 Cell Line |
embryonic stem cell
|
8 |
chr6:33943600-33944200 |
Active TSS |
ES-UCSF4 Cell Line |
embryonic stem cell
|
9 |
chr6:33943600-33944200 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
10 |
chr6:33943600-33944200 |
Bivalent Enhancer |
Primary T helper cells PMA-I stimulated |
--
|
11 |
chr6:33943600-33944200 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
12 |
chr6:33943800-33944200 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
13 |
chr6:33943800-33944200 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
14 |
chr6:33943800-33944200 |
Bivalent/Poised TSS |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
15 |
chr6:33943800-33944200 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
16 |
chr6:33943800-33944200 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
17 |
chr6:33943800-33944200 |
Bivalent/Poised TSS |
Brain Germinal Matrix |
brain
|
18 |
chr6:33943800-33944800 |
Bivalent/Poised TSS |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
19 |
chr6:33944000-33944200 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
20 |
chr6:33944000-33944200 |
Flanking Bivalent TSS/Enh |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
21 |
chr6:33944000-33944200 |
Bivalent Enhancer |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
22 |
chr6:33944000-33944200 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
23 |
chr6:33944000-33944200 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
24 |
chr6:33944000-33944200 |
Bivalent Enhancer |
Primary T cells from cord blood |
blood
|
25 |
chr6:33944000-33944200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
26 |
chr6:33944000-33944200 |
Bivalent Enhancer |
Primary hematopoietic stem cells short term culture |
blood
|
27 |
chr6:33944000-33944200 |
Bivalent Enhancer |
Primary T helper naive cells fromperipheralblood |
blood
|
28 |
chr6:33944000-33944400 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
29 |
chr6:33944000-33944400 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
30 |
chr6:33944000-33944400 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
31 |
chr6:33944000-33944400 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
32 |
chr6:33944000-33944400 |
Flanking Active TSS |
Rectal Mucosa Donor 31 |
rectum
|
33 |
chr6:33944000-33944800 |
Bivalent Enhancer |
Rectal Mucosa Donor 29 |
rectum
|